Delivery Order SPE2DR25D9113-SPE2DR26FCHX8
Award Date 2/11/26
Potential Completion Date 2/12/26
Potential Value $13K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency issued a $37,989.81 delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, on February 6, 2026, for supply of Jakafi 10 mg tablets under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract authorizing firm fixed-price delivery orders for pharmaceutical products and medical consumables to support Department of Defense healthcare operations worldwide....
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on February 12, 2026, for $25,326.56 (firm fixed price) under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) for supply of Jakafi 10 mg tablets. PPV-G GEN V is the Defense Logistics Agency's indefinite delivery contract vehicle for pharmaceutical products including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables to support...
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on February 11, 2026, for Jakafi 5 mg tablets (60-count units) with a ceiling value of $25,441.84, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract supporting pharmaceutical supply to Department of Defense healthcare facilities worldwide. DMS Pharmaceutical Group Inc. is a woman-owned small business...
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on February 10, 2026, with a ceiling value of $55,678.45, for supply of JAKAFI 10 mg tablets (60-count units) under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract authorizing firm fixed-price delivery orders for pharmaceutical products, branded and generic prescription drugs, over-the-counter medications,...
- The Defense Logistics Agency issued a $25,326.56 delivery order to DMS Pharmaceutical Group Inc. on February 9, 2026, for Jakafi 10 mg tablets under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract authorizing firm fixed-price delivery orders for pharmaceutical products including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables to support...
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on February 6, 2026, for $75,497.70 under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) for supply of Jakafi 15 mg tablets (60-count units). PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract supporting pharmaceutical supply to Department of Defense military healthcare facilities worldwide. The order is firm fixed price with an ultimate completion date of February...
- The Defense Logistics Agency issued a $12,582.95 delivery order to DMS Pharmaceutical Group Inc. on February 5, 2026, for Jakafi 15 mg tablets under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). PPV-G GEN V is a Defense Logistics Agency single-award indefinite delivery contract authorizing firm fixed-price delivery orders for branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables to support Department of Defense...
- The Defense Logistics Agency issued a $50,883.68 delivery order to DMS Pharmaceutical Group Inc. on February 6, 2026, for JAKAFI 5 mg tablets (60-count units) under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). PPV-G GEN V is a DLA-administered indefinite delivery contract authorizing firm fixed-price delivery orders for pharmaceutical products, including branded and generic prescription drugs, biologics, and medical consumables to support Department of Defense...
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on February 11, 2026, for supply of Jakafi 10 mg tablets (60-count), with a ceiling value of $25,326.56 and an ultimate completion date of February 12, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). DMS Pharmaceutical Group Inc. is a woman-owned small business. The parent contract (SPE2DR), a single-award Indefinite Delivery Contract with a $499,999,999 ceiling, was...
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on February 9, 2026, with a ceiling value of $18,516.41 for supply of JAKAFI 5 mg tablets (60 count) under its Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) indefinite delivery contract. DMS Pharmaceutical Group Inc. is a woman-owned small business. Place of performance is Park Ridge, IL. The order is firm fixed price with an ultimate completion date of February 10, 2026. PPV-G GEN V...